What You Should Know:
- SURGE Therapeutics (SURGE) recently announced the completion of a $26 million Series A financing led by Camford Capital, with participation from Khosla Ventures, Intuitive Ventures, Pitango HealthTech, 8VC, Alumni Ventures, and the Cancer Research Institute.
- The funds will be used to accelerate the development of the SURGE™ intraoperative immunotherapy approach, expand the team, and initiate clinical trials for its injectable biodegradable hydrogel.
Using
Read More
Khosla Ventures
GE Healthcare Makes Strategic Investment in AliveCor
What You Should Know:
- AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, recently announced its Series F Financing led by GE Healthcare.
- The round also included participation from Pegasus Tech Ventures) and existing investors including Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, and WP Global Partners.
Providing End-to-End Cardiological Care Using Subscription Services
AliveCor, Inc. is transforming cardiological care using deep
Read More
Valo Health and Khosla Ventures Merge to Go Public in $2.8B SPAC Deal
What You Should Know:
Valo Health, the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process, and Khosla Ventures Acquisition Co. ("KVAC") (NASDAQ: KVSA), a special purpose acquisition (SPAC), announced today that they have entered into a definitive merger agreement.
- The SPAC deal represents a pro forma market value of approximately $2.8B for the combined company. The combined company is
Read More
SWORD Health Nabs $25M for Virtual Musculoskeletal Care Solution
What You Should Know:
- SWORD Health raises $25 million in Series B to accelerate growth of its best-in-class virtual musculoskeletal care solution led by Todd Cozzens, Managing Partner at Transformation Capital and former healthcare investor at Sequoia Capital. Existing investors Khosla Ventures, Founders Fund, Green Innovations, Vesalius Biocapital and Faber also participated. The latest round brings SWORD’s cumulative fundraising to $50 million.
- SWORD Health pairs licensed physical
Read More
Cellino Closes $16M Seed Financing led by The Engine and Khosla Ventures to Automate and Scale Stem Cell Manufacture
What You Should Know:
- Cellino, a Cambridge, MA-based personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced the closing of a $16M Seed financing round. The round was co-led by The Engine and Khosla Ventures, with participation from Humboldt Fund and 8VC.
- The company’s platform solves a time-consuming, major bottleneck of developing drugs that rely on cell therapy, having to
Read More
Caption Health Nabs $53M to Commercialize FDA-Cleared AI-Guided Ultrasound Technology
What You Should Know:
- Caption Health raises $53 million series B round to
fuel commercialization and expansion of its FDA-approved AI ultrasound
technology. This is on the heels of its receiving FDA clearance, designated as
a breakthrough technology to fight against COVID-19.
- As ultrasounds, especially cardiac ultrasounds, have
become increasingly important during a time of COVID when resources are
stretched, using AI to help more healthcare professionals take high-quality
images is
Read More
HeartVista Raises $8.65M to Expand One Click, AI-Guided MRI Platform
What You Should Know:
HeartVista, a pioneer in AI-assisted MRI solutions raises
$8.65M in Series A funding led by Khosla Ventures, Jeff Rothschild, Leslie
Ventures, Open Field Capital, and additional investors.
The startup plans to use the funding to fuel new
musculoskeletal and neural products, expand internationally, and deepen
strategic alliances with the world’s leading cardiology centers.
HeartVista,
a pioneer in AI-assisted MRI solutions, today announced the closing of a
Read More
Analysis: November 2019 Health IT M&A Activity, Public Company Performance
– Healthcare Growth Partners' (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of November 2019We did a doubletake when we noticed all of the HGP healthcare indices climbed approximately 10% during the month of November. Year-to-date, the S&P 500 is up over 25% and the HGP healthcare indices are all hovering in that range. In the two month period since September, when talk of universal healthcare reached
Read More
UK Startup Flow Launches Chatbot Therapist to Combat Depression
- UK startup launches Flow, a chatbot therapist engages users with daily chat conversations and offers self-help techniques, mood tracking, curated videos, meditation, and mental exercises.
- Available to download free on iOS, the chatbot therapist is based on the latest psychology and neuroscience research and was developed by clinical psychologists and machine learning experts.
- To maximize the chance of recovery, Flow can be used in conjunction with the Flow brain stimulation
Read More
UK Startup Flow Raises $1.5M for Brain Stimulation Headset, Therapy App
Flow, a London-based medical device startup using a brain stimulation headset and therapy app to treat depression has raised $1.5 million in seed funding led by Khosla Ventures. In Europe, Flow has been approved as a Class II medical device intended for use as a treatment for depression – and is the first approved treatment of its kind in Europe available to buy and use at home. The investment will be used to support Flow’s European rollout, introduce Flow to healthcare clinics, and fund
Read More
